Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
Abstract Background In patients with vasodilatory shock, plasma concentrations of angiotensin I (ANG I) and II (ANG II) and their ratio may reflect differences in the response to severe vasodilation, provide novel insights into its biology, and predict clinical outcomes. The objective of these proto...
Main Authors: | Rinaldo Bellomo, Richard G. Wunderink, Harold Szerlip, Shane W. English, Laurence W. Busse, Adam M. Deane, Ashish K. Khanna, Michael T. McCurdy, Marlies Ostermann, Paul J. Young, Damian R. Handisides, Lakhmir S. Chawla, George F. Tidmarsh, Timothy E. Albertson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-2733-x |
Similar Items
-
Angiotensin converting enzyme defects in shock: implications for future therapy
by: Lakhmir S. Chawla, et al.
Published: (2018-10-01) -
How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review
by: Semedi BP, et al.
Published: (2023-01-01) -
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
by: Daniel E. Leisman, et al.
Published: (2023-12-01) -
Renin Angiotensin System (RAS) Pathways in COVID Pathogenesis
by: Sampreeti Mukherjee, et al.
Published: (2023-01-01) -
Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)